PROFFERED PAPERS
Tuesday, March 4   —  8:00 AM   —  CC Korbel BR 4


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




Section C - GYNECOLOGIC PATHOLOGY
Chaired by: Debra Bell and Joseph Rabban



TimeTitle and AuthorsItinerary
Planner
8:00 Ovarian Serous Borderline Tumors with a Predominant Micropapillary Pattern Are Aggressive Neoplasms with an Increased Risk for Low Grade Serous Carcinoma (1011)
AA Roma, A Malpica, MT Deavers, EG Silva - MD Anderson Cancer Center, Houston, TX
Add
8:15 BRAF, ERK and p16 in Ovarian Serous Tumorigenesis (1022)
PW Schlosshauer, D Fatemi, M Pearl, L Deligdisch, F Penault-Llorca, R Qiao, H Shen, J Dong - The Mount Sinai School of Medicine, New York, NY; Weill Medical College of Cornell University, New York, NY; Centre Jean Perrin, Clermont-Ferrand, France; University of Texas Medical Branch, Galveston, TX
Add
8:30 Significant Genes and Pathways Involved in Low Grade Ovarian Carcinogenesis (976)
T May, M Sharma, I Jurisica, H Begley, B Rosen, KJ Murphy, T Brown, P Shaw - University of Toronto, Toronto, ON, Canada; Ontario Cancer Institute, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada; Princess Margaret Hospital, Toronto, ON, Canada
Add
8:45 Distinct Signatures of DNA Copy Number Changes in Ovarian Surface Epithelial Tumors (974)
T-L Mao, N Jinawath, RJ Kurman, T-L Wang, I-M Shih
Johns Hopkins Medical Institutions, Baltimore, MD; National Taiwan University Hospital, Taipei, Taiwan
Add
9:00 The Metastasis-Associated Protein 1 Is a Prognostic Biomarker for Papillary Serous Ovarian Carcinoma (943)
MD Hofer, J Liu, MA Rubin, UA Matulonis, MS Hirsch - Brigham and Women's Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA
Add
9:15 Array Comparitive Genomic Hybridization Detects Discriminatory Chromosomal Abnormalities between Primary Peritoneal Papillary Serous Carcinoma and Ovarian Papillary Serous Carcinomas (958)
M Kapali, C Cieply, M Chivukula, S Dacic - University of Pittsburgh Medical Center, Pittsburgh, PA; Southern Arizona VA Health System, Tucson, AZ
Add
9:30 RECESS, EXHIBITS, POSTER SESSION III  
11:00 Serous Cancer Precursors in Fallopian Tube Epithelium of BRCA1/2 Mutation Carriers (1024)
PA Shaw, M Rouzbahman, ES Pizer, M Pintilie, H Begley
University Health Network, Toronto, Canada; Cellnetix Pathology, Seattle
Add
11:15 Pathologic and Epidemiologic Study of a Candidate Precursor to Pelvic Serous Cancer in BRCA+ Women (933)
A Folkins, L Garrett, A Saleemuddin, S Tworoger, CP Crum - Brigham and Women's Hospital, Boston, MA
Add
11:30 Ovarian Clear Cell Carcinoma May Arise from Two Different Precursors with Different Clinico-Pathologic Features (1040)
E Veras, TL Mao, A Ayhan, IM Shih, R Kurman - Johns Hopkins Hospital, Baltimore, MD; National Taiwan University Hospital, Taiwan; Seirei Mikatahara General Hospital, Hamamatsu, Japan
Add
11:45 Histologically Indolent Thyroid Carcinoma Arising in Struma Ovarii Can Recur and Metastasize (938)
K Garg, M Rivera, RA Soslow, R Ghossein - MSKCC, New York, NY
Add